12:29 Feb 25

Abbott India Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
26330.00
-35.00 (-0.13%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Abbott India Ltd. Financials

Abbott India Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
26330.00
-35.00 (-0.13%)
12:29 Feb 25
Quality
image/svg+xml

79/100
High Financial Strength

Valuation
image/svg+xml

29/100
Expensive Valuation

Technical

31/100
Technically Bearish

Strength

6

Weakness

5

Opportunity

2

Threats

1

33.41 %

ROE %

23.90 %

ROA %

717.26

EPS

1,992.07

BVPS

0.00 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
4310.02 4919.27 5348.73 5848.91 6409.15
Operating Expenses +
3388.56 3831.55 4143.1 4395.81 4714.55
Raw Material
2494.92 2679.49 2908.97 3212.88 3677.46
Increase Decrease in Cost
-104 -22.28 66.09 7.73 -180.68
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
492.65 579.46 563.59 576.58 587.54
Miscellaneous Expenses
4586.19 4962.94 5305.17 5893.04 6742.91
Operating Profit
921.46 1087.72 1205.63 1453.1 1694.6
Other Income
80.9 77.21 154.15 248.27 275.58
Depreciation
58.13 66.1 69.97 71.17 71.8
Interest
18.28 19.1 15.99 12.45 11.43
Profit before tax and exceptio..
925.95 1079.73 1273.82 1617.75 1886.95
Exceptional Items
0 0 0 0 0
PBT
925.95 1079.73 1273.82 1617.75 1886.95
Provision for Taxation
235.26 281.03 324.41 416.53 472.51
Net Profit
690.69 798.7 949.41 1201.22 1414.44
NET Profit after MI
0 0 0 0 0
EPS
325.04 375.86 446.78 565.28 665.62
Operating Profit Margin (%)
21.38 22.11 22.54 24.84 26.44
Net Profit Margin (%)
16.03 16.24 17.75 20.54 22.07

Abbott India Ltd. Shareholding

All Data in Percentage (%)

Sep 2024 Dec 2024 Mar 2025 Jun 2025 Sep 2025 Dec 2025
Promoter 75.00 75.00 75.00 75.00 75.00 75.00
FII 0.20 0.20 0.20 0.20 0.20 0.20
Public 9.00 9.10 9.10 8.90 9.00 9.00
Others 15.80 15.70 15.70 15.90 15.80 15.80
Shareholder Shares Holding %
Download Our App On: